利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.009 秒)

    AMINO ACID COMPLEXES OF C-ARYL GLUCOSIDES FOR TREATMENT OF DIABETES AND METHOD
    3.
    发明公开
    AMINO ACID COMPLEXES OF C-ARYL GLUCOSIDES FOR TREATMENT OF DIABETES AND METHOD 有权
    c-ARYLGLYCOSIDEN糖尿病和程序的处理氨基配

    公开(公告)号：EP1385856A4

    公开(公告)日：2005-05-11

    申请号：EP02723801

    申请日：2002-04-08

    申请人： SQUIBB BRISTOL MYERS CO

    发明人： GOUGOUTAS JACK Z

    IPC分类号： C07H7/04 ,  A61K31/351 ,  A61K31/7004 ,  A61K45/06 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P17/02 ,  A61P27/02 ,  C07D309/10 ,  C07H15/203 ,  A61K31/70

    CPC分类号： A61K45/06 ,  A61K31/351 ,  C07H15/203 ,  Y10S514/866 ,  A61K2300/00

    摘要： Crystalline complexes are obtained from a 1:1 or 2:1 mixtures of either the (D) or (L) enantiomer of natural amino acids and compounds of formula (I) wherein R1, R2 and R2a are independently hydrogen, OH, OR5, alkyl, -OCHF?2, -OCF3¿, -SR¿5a? or halogen; R3 and R4 are independently hydrogen, OH, OR5b, alkyl, cycloalkyl, CF?3, -OCHF2, -OCF3¿, halogen, -CONR¿6?R6a, -CO?2R¿5c, -CO2H, -COR¿6b?, -CH(OH)R6c, -CH(OR5d)R6d, -CN, -NHCOR5e, -NHSO?2R¿5f, -NHSO2Aryl, -SR¿5g?, -SOR5h, -SO?2R¿5i, or a five, six or seven membered heterocycle which may contain 1 to 4 heteroatoms in the ring which are N, O, S, SO, and/or SO2, or R¿3? and R4 together with the carbons to which they are attached form an annelated five, six or seven membered carbocycle or heterocycle which may contain 1 to 4 heteroatoms in the ring which are N, O, S, SO, and/or SO?2; R¿5, R5a, R5b, R5c, R5d, R5e, R5f, R5g, R5h and R5i are independently alkyl; R6, R6a, R6b, R6c and R6d are independently hydrogen, alkyl, aryl, alkylaryl or cycloalkyl, or R6 and R6a together with the nitrogen to which they are attached form an annelated five, six or seven membered heterocycle which may contain 1 to 4 heteroatoms in the ring which are N, O, S, SO, and/or SO2. A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above complex alone or in combination with another antidiabetic agent or other therapeutic agent.